PML-driven sumoylation of PML::RARA-bound repressors drives hematopoietic progenitor immortalization.

PML::RARA fusion enhances hematopoietic progenitor immortalization by promoting sumoylation of repressive complexes, with UBC9 recruitment being essential for transformation.

• Why it matters: Understanding why PML and RARA are recurrent fusion partners in APL could reveal key mechanisms of leukemia development and identify potential therapeutic targets.
• What they did: The study used molecular approaches to show that PML recruits UBC9 to PML::RARA, leading to SUMO2 modification of corepressors like NCoR, which enhances repression and drives cell immortalization.
• The result: Inhibiting sumoylation reactivates retinoic acid target genes and induces differentiation in PML::RARA-expressing cells, suggesting sumoylation as a potential therapeutic intervention in APL.